A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis

Citations Over TimeTop 10% of 2017 papers

Abstract

T helper 9 (Th9) cells contribute to lung inflammation and allergy as sources of interleukin-9 (IL-9). However, the mechanisms by which IL-9/Th9 mediate immunopathology in the lung are unknown. Here we report an IL-9-driven positive feedback loop that reinforces allergic inflammation. We show that IL-9 increases IL-2 production by mast cells, which leads to expansion of CD25+ type 2 innate lymphoid cells (ILC2) and subsequent activation of Th9 cells. Blocking IL-9 or inhibiting CD117 (c-Kit) signalling counteracts the pathogenic effect of the described IL-9-mast cell-IL-2 signalling axis. Overproduction of IL-9 is observed in expectorates from cystic fibrosis (CF) patients, and a sex-specific variant of IL-9 is predictive of allergic reactions in female patients. Our results suggest that blocking IL-9 may be a therapeutic strategy to ameliorate inflammation associated with microbial colonization in the lung, and offers a plausible explanation for gender differences in clinical outcomes of patients with CF.

Related Papers

• → IL-13 mediates IL-33–dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cells(2015)36 cited
• → Soluble ST2 suppresses the effect of interleukin-33 on lung type 2 innate lymphoid cells(2016)22 cited
• → Cutting Edge: CCR8 Signaling Regulates IL-25– and IL-33–Responsive Skin Group 2 Innate Lymphoid Cell Migration and Function(2023)2 cited
• → c-Rel is required for IL-33-dependent activation of ILC2s(2021)1 cited
• → [Type 2 innate lymphoid cells and chronic rhinosinusitis].(2016)